首页> 美国政府科技报告 >Enhancement of the Efficacy of Conventional Anticancer Compounds Through the Repression of SNAI Proteins in Aggressive Breast Cancer Cells.

【24h】

Enhancement of the Efficacy of Conventional Anticancer Compounds Through the Repression of SNAI Proteins in Aggressive Breast Cancer Cells.

机译：通过在侵袭性乳腺癌细胞中抑制sNaI蛋白增强常规抗癌化合物的功效。

获取原文

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Chaudhuri, G.;
展开▼
作者单位

展开▼
年度 2014
页码 1-24
总页数 24
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. 在体内和体外条件下阿奇霉素通过抑制自噬和上调结肠癌细胞内DR4/5蛋白水平增强TRAIL抗癌活性 [J] . Xinran Qiao, Xiaofei Wang, Yue Shang, 癌症（英文版） . 2018,第012期
2. Co-delivery of doxorubicin and P-glycoprotein siRNA by multifunctional triblock copolymers for enhanced anticancer efficacy in breast cancer cells [J] . Xu Minghui, Qian Junmin, Suo Aili, Journal of Materials Chemistry, B. materials for biology and medicine . 2015,第10期

机译：多功能三嵌段共聚物共同递送阿霉素和P-糖蛋白siRNA以增强乳腺癌细胞的抗癌功效
3. SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer [J] . Carla L. Alves, Daniel Elias, Maria B. Lyng, Breast Cancer Research . 2018,第1期

机译：SNAI2上调与耐氟维司群的乳腺癌细胞的侵袭性表型有关，并且是雌激素受体阳性转移性乳腺癌对内分泌治疗反应不良的指标
4. Antisense oligodeoxynucleotide directed against c-myb has anticancer activity and potentiates the antiproliferative effect of conventional anticancer drugs acting by different mechanisms in human colorectal cancer cells. [J] . Abaza MS, Al-Attiyah RJ, Al-Saffar AM, Tumour biology : . 2003,第5期

机译：针对c-myb的反义寡聚脱氧核苷酸具有抗癌活性，并增强了常规抗癌药物通过不同机制作用于人结直肠癌细胞的抗增殖作用。
5. Identification of proteins modified by the lipid peroxidation aldehyde DODE in MCF7 breast cancer cells. [C] . Peter G. Slade, Michelle V. Williams, Viral Brahmbhtt, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2009

机译：MCF7乳腺癌细胞中脂质过氧化醛DODE改性蛋白质的鉴定。
6. Effects of membrane lateral organization on the anticancer activity of liposomal Ca4P against MCF-7 breast cancer cells. [D] . Zhu, Weiwei. 2010

机译：膜的横向组织对脂质体Ca4P对MCF-7乳腺癌细胞抗癌活性的影响。
7. SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer [O] . Carla L. Alves, Daniel Elias, Maria B. Lyng, 2018

机译：SNAI2上调与耐氟维司特的乳腺癌细胞的侵袭性表型有关并且是雌激素受体阳性转移性乳腺癌对内分泌治疗反应不良的指标
8. Novel bisnaphthalimidopropyl (BNIPs) derivatives as anticancer compounds targeting DNA in human breast cancer cells. [O] . Kopsida Maria, Barron Gemma A., Bermano Giovanna, 2016

机译：新型双萘二甲酰亚胺基丙基（BNIPs）衍生物作为靶向人类乳腺癌细胞中DNA的抗癌化合物。
9. Enhancement of the Efficacy of Conventional Anticancer Compounds through the Repression of SNAI Proteins in Aggressive Breast Cancer Cells. [R] . Chaudhuri, G. 2012

机译：通过在侵袭性乳腺癌细胞中抑制sNaI蛋白增强常规抗癌化合物的功效。

Enhancement of the Efficacy of Conventional Anticancer Compounds Through the Repression of SNAI Proteins in Aggressive Breast Cancer Cells.

著录项

引文网络

相似文献

相关主题

期刊订阅